Coherently, it has also been observed that APP knock down in melanoma cells [71] and in pancreatic cancer [72] enhanced the cytotoxicity of different chemotherapeutic agents, indicating that the presence of amyloid fibrils can indeed modulate response to drugs. This evidence concerns the gene APP and pancreatic neoplasm.